$72.11
0.731.02%
At close: -
$72.11
0.000.00%
After Hours: 4:37 PM EDT
Comments
Loading...
Latest news for Incyte (NASDAQ:INCY) Stock
Incyte Stock (NASDAQ: INCY)
Categories: All
Thursday, February 20, 2025
Thursday, February 13, 2025
Tuesday, February 11, 2025
Monday, February 10, 2025
- Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?
- Incyte Unusual Options Activity
- Incyte shares are trading lower after the com...
- Incyte Q4 Earnings: EPS Miss, Strong Jakafi And Opzelura Sales, Says 2025 To Be Catalyst Rich Including 4 Launches
- Insights into Incyte Q4 Earnings
- Incyte Forecasts 2025 Jakafi Revenue Of $2.92...
- Incyte Q4 2024 Adj EPS $1.43 Misses $1.56 Est...
- Earnings Scheduled For February 10, 2025
Thursday, January 23, 2025
- RBC Capital Reiterates Sector Perform on Incy...
- Insider Decision Unfolding At Incyte: Matteo Trotta Exercises Options, Resulting In $0
- Notable Insider Move: PABLO CAGNONI Takes Part In Options Exercise At Incyte, Resulting In $0
- Thomas Tray Expands Holdings With Incyte Stock Options Worth $1K
- In A Strategic Move, Christiana Stamoulis Acquires Incyte Stock Options Worth $8K: Enhancing Value
- Vijay Iyengar Backs Up Beliefs With A Notable Acquisition Of Incyte Stock Options Worth $5K
- PAULA SWAIN Decides To Exercise Options At Incyte Worth $0
Wednesday, January 15, 2025
Tuesday, January 14, 2025
Friday, January 10, 2025
Thursday, December 19, 2024
Tuesday, December 10, 2024
Saturday, December 07, 2024
Monday, November 25, 2024
Sunday, November 24, 2024
Tuesday, November 19, 2024
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Gold Moves Higher; Medtronic Posts Upbeat Results
- Stocks Move Higher, Walmart Hits Record High, Natural Gas Reaches 5-Month Peak: What's Driving Markets Tuesday?
- Incyte Shares Resume Trade
- Watching Incyte; Sky News City Editor Mark Kl...
- Incyte Shares Halted On Circuit Breaker To Th...
- What's Going On With Incyte Shares Tuesday?
- Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
- Nasdaq Gains 100 Points; Lowe's Earnings Beat Views
- RBC Capital Maintains Sector Perform on Incyt...
- Cantor Fitzgerald Reiterates Neutral on Incyt...
- Incyte shares are trading lower after the com...
- Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket